Exophilin: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
Line 1: Line 1:
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''>
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''>
This is a default text for your page '''Exophilin'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.


== Function ==
== Function ==


'''Exophilin''' (EXP) are [[Synaptotagmin]]-like membrane proteins which bind Ca+2 and phospholipids are involved in synaptic vesicle docking.  EXP-1 or '''rabphilin-3A'''
'''Exophilin''' (EXP) are [[Synaptotagmin]]-like membrane proteins which bind Ca+2 and phospholipids are involved in synaptic vesicle docking.  EXP-1 or '''rabphilin-3A''' is a rab3 effector at the synapse.  Rab3A is a GTP-binding protein of synaptic vesicle that regulates vesicle exocytosis<ref>PMID:10407024</ref>.  EXP-1 regulates synaptic vesicle traffic and does so at distinct stages of both the exocytotic and endocytotic pathways<ref>PMID:9450942</ref>.


== Disease ==
== Disease ==


== Relevance ==
== Relevance ==
EXP-1 is a diagnostically useful autoantigen for lymphocytic infundibulo-neurohypophysitis<ref>PMID:25919460</ref>.  Reduction of EXP-1 immunoreactivity was found in patients of Alzheimer disease<ref>PMID:24200817</ref>.


== Structural highlights ==
== Structural highlights ==

Revision as of 11:31, 4 December 2018

Caption for this structure

Drag the structure with the mouse to rotate

3D structures of exophilin

Updated on 04-December-2018

References

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky